CTRI/2018/08/015222已完成3 期
Phase 3 randomised controlled trial comparing the effectiveness of dexamethasone in reducing cancer associated fatigue in patients on palliative chemotherapy.
Cancer Institute0 个研究点目标入组 126 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 126
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients above 18 years and less than 60 years of age
- •2. Diagnosed with advanced breast or lung cancer and planned for palliative intravenous chemotherapy.
- •3. Not received chemotherapy in the preceding one month.
- •4. ECOG performance score of less than or equal to 2.
- •5. Normal cognition.
- •6. No contraindications to steroids.
- •7. Absence of active infection
- •8. Signed informed consent.
排除标准
- •1. History of diabetes mellitus or hypertension.
- •2. Past history of peptic ulcer or gastrointestinal bleed.
- •3. Congestive heart failure and ischemic heart disease.
- •4. Diseases like brain tumors and prostate cancer were corticosteroids are part of the treatment. Use of corticosteroids as anti-emetic is permitted.
- •5. Patient is mentally incapacitated or has a significant emotional or psychiatric disorder that, in the opinion of the investigator, precludes study entry.
- •6.Renal failure, hepatic failure, glaucoma, epilepsy.
- •7. HIV, HBV or HCV positive
研究者
相似试验
已完成
3 期
Study to find out if restricting raw fruits in patients with blood cancer can reduce infections.CTRI/2018/01/011418Cancer Institute200
进行中（未招募）
1 期
A randomised controlled phase III trial comparing hyperthermia plus mitomycin to a second course of bacillus Calmette-Guerin or standard therapy in patients with recurrence of non-muscle invasive bladder cancer following induction or maintenance bacillus Calmette-Guerin therapy. - Hyperthermia plus mitomycin (HYMN)on muscle invasive bladder cancerMedDRA version: 9.1 Level: LLT Classification code 10005006 Term: Bladder cancer stage 0, with cancer in situMedDRA version: 9.1 Level: LLT Classification code 10005007 Term: Bladder cancer stage 0, without cancer in situMedDRA version: 9.1 Level: LLT Classification code 10005008 Term: Bladder cancer stage I, with cancer in situMedDRA version: 9.1 Level: LLT Classification code 10005009 Term: Bladder cancer stage I, without cancer in situEUCTR2008-005428-99-GBniversity College London104
招募中
1 期
A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of two formulations of vaginal micronized progesterone.infertilityCTIS2024-513102-57-00Santiago Dexeus Font Fundacio Privada1,020
招募中
3 期
A randomized controlled phase III study comparing docetaxel, cisplatin and 5-FU (2-weekly DCF) with cisplatin and 5-FU (CF) in patients with metastatic or recurrent esophageal cancer (JCOG1314, MIRACLE study)esophageal cancerJPRN-UMIN000015107Japan Clinical Oncology Group (JCOG)240
尚未招募
3 期
To Study effectiveness of oral chemotherapy with low dose immunotherapy compared with chemotherapy in Head and Neck Cancer PatientsCTRI/2024/01/061661Tata Memorial Centre